Cabergol Tablet 0.5 mg is a dopamine agonist that is used to treat conditions such as, hyperprolactinemia, Parkinson’s Disease, and reproductive disorders. It is readily available in both oral and intravenous forms.
Cabergol Tablet 0.5 mg is used to treat hyperprolactinemia, a condition in which the body produces too much of the hormone prolactin. It is also used to treat Parkinson's disease, infertility, and uses off-label for other conditions.
Cabergol Tablet 0.5 mg works by activating dopamine receptors, which helps to reduce the amount of prolactin released by the pituitary gland.
Cabergol Tablet 0.5 mg typically starts working soon after taking it. However, it may take up to two weeks for therapeutic levels of the medication to be reached in the body.
Cabergol Tablet 0.5 mg is rapidly and well absorbed from the gastrointestinal tract and is widely distributed throughout the body.
Cabergol Tablet 0.5 mg is mainly eliminated through the kidneys; approximately 80% of the drug is excreted in the urine.
The exact dosage of Cabergol Tablet 0.5 mg depends on the severity of the condition being treated and the individual's response to the drug. For hyperprolactinemia, the initial dose is typically 0.5 to 1 mg twice weekly, and the maximum is 4 mg per week.
Cabergol Tablet 0.5 mg is available as a pill and is to be taken orally. The tablets can be taken with or without food.
The most common side effects of Cabergol Tablet 0.5 mg include nausea, vomiting, diarrhea, constipation, dizziness, headache, tiredness, and difficulty sleeping.
Cabergol Tablet 0.5 mg is generally well-tolerated when taken as prescribed, however it can cause serious toxicity if taken in large amounts.
This medication should not be taken by anyone who is allergic to cabergoline or any of its ingredients. Women who are pregnant or breastfeeding should consult a physician to discuss the risks.
Cabergol Tablet 0.5 mg can interact with certain medications, herbs, or supplements. Patients should inform their healthcare provider about all medications they are taking before beginning therapy.
Cabergol Tablet 0.5 mg should not be used by patients with uncontrolled hypertension, severe heart or liver disease, and uncontrolled psychotic disorders.
Cabergol Tablet 0.5 mg can interact with certain medications, such as certain antidepressants, antipsychotics, and anti-seizure medications.
Grapefruit and grapefruit juice should not be used while taking Cabergol Tablet 0.5 mg as they can increase the risk of side effects.
Cabergol Tablet 0.5 mg should only be used by pregnant women only when absolutely necessary, as the risks outweigh the benefits.
Cabergol Tablet 0.5 mg should not be used by breastfeeding women as it can pass into breast milk and may cause harm to the infant.
In the event of an acute overdose, seek medical attention immediately. Symptoms can include severe nausea, vomiting, diarrhea, and dizziness.
Cabergol Tablet 0.5 mg should not be used in patients who are hypersensitive to the drug or any of its inactive ingredients.
Cabergol Tablet 0.5 mg is generally taken orally with or without food two times each week, according to the instructions of a healthcare provider.
Store Cabergol Tablet 0.5 mg at room temperature, away from direct sunlight and heat.
Cabergol Tablet 0.5 mg has an apparent volume of distribution of approximately 0.35 L/kg.
The half-life of cabergoline is approximately 63 - 68 hours.
Cabergol Tablet 0.5 mg is cleared from the body primarily via the kidneys; approximately 80% is excreted as metabolites.
See in details version Cabergol Tablet 0.5 mg also Cabergol Tablet 0.5 mg in bangla